FHIR IG analytics| Package | uz.dhp.integrations |
| Resource Type | ValueSet |
| Id | ValueSet-dhis-observation-component-code-vs.json |
| FHIR Version | R5 |
| Source | https://build.fhir.org/ig/uzinfocom-org/digital-health-integration/ValueSet-dhis-observation-component-code-vs.html |
| URL | https://terminology.dhp.uz/fhir/integrations/ValueSet/dhis-observation-component-code-vs |
| Version | 0.1.0 |
| Status | draft |
| Date | 2026-07-20T13:54:46+00:00 |
| Name | DHISObservationComponentCodeVS |
| Title | DHIS Observation Component Code ValueSet |
| Description | Value set of tuberculosis observation component codes. Plain drug-name DST agents use their LOINC [Susceptibility] code directly; concentration-bearing agents and non-drug component codes use local codes from the DHIS observation component code system. |
| StructureDefinition | ||
| uz.dhp.integrations#current | dhis-observation-hiv | DHIS Observation HIV Profile |
| uz.dhp.integrations#current | dhis-observation-microscopy | DHIS Observation Microscopy Profile |
| uz.dhp.integrations#current | dhis-observation | DHIS Observation Profile |
| CodeSystem | ||
| kl.dk.fhir.children#2.1.0 | loinc.org | Logical Observation Identifiers, Names and Codes (LOINC) |
| uz.dhp.integrations#current | dhis-observation-component-code-cs | DHIS Observation Component Code CodeSystem |
Note: links and images are rebased to the (stated) source
English
Generated Narrative: ValueSet dhis-observation-component-code-vs
Language: uz
This value set includes codes based on the following rules:
FHIR
FHIRsmithhttps://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs version 📍0.1.0| Code | Display |
| tub004-0001 | INH ↑ MIK natijasi |
| tub004-0002 | INH ↓ MIK / ETH natijasi |
| tub004-0003 | FQL ↑ MIK natijasi |
| tub004-0004 | FQL ↓ MIK natijasi |
| tub004-0005 | AMK/KAN/CAP natijasi |
| tub004-0006 | AMK/KAN natijasi |
| tub004-0007 | Rifampitsin (1,0 mg/ml) |
| tub004-0008 | Izoniazid (0,1 mg/ml) |
| tub004-0009 | Etambutol (5,0 mg/ml) |
| tub004-0010 | Pirazinamid (100 mg/ml) |
| tub004-0011 | Levofloksatsin (2,0 mg/ml) |
| tub004-0012 | Moksifloksatsin (1,0 mg/ml) |
| tub004-0013 | Moksifloksatsin (0,25 mg/ml) |
| tub004-0014 | Gatifloksatsin (0,25 mg/ml) |
| tub004-0015 | Amikatsin (1,0 mg/ml) |
| tub004-0016 | Protionamid (2,5 mg/ml) |
| tub004-0017 | Linezolid (1,0 mg/ml) |
| tub004-0018 | Klofazimin (1,0 mg/ml) |
| tub004-0019 | Bedaquilin (1,0 mg/ml) |
| tub004-0020 | Delamanid (0,06 mg/ml) |
| tub004-0021 | Pretomanid (1,0 mg/ml) |
| tub004-0023 | Isoniazid ↑MIC |
| tub004-0024 | Isoniazid ↓MIC |
| tub004-0025 | Ethionamide-Prothionamide |
| tub004-0026 | Moxifloxacin ↑MIC |
| tub004-0027 | Moxifloxacin ↓MIC |
| tub004-0031 | CM/AS izolyatini identifikatsiya qilish |
| tub004-0032 | Gradatsiya |
| tub004-0033 | Kultura identifikatsiyasi |
| tub004-0034 | M. tuberculosis complex aniqlash natijasi |
| tub004-0035 | CM/AS izolyatini identifikatsiya qilish |
| tub004-0036 | ARVT (Antiretrovirusli terapiya) |
| tub004-0037 | KTR boshlandi |
http://loinc.org version Not Stated (use latest from terminology server)| Code | Display |
| 18974-6 | rifAMPin [Susceptibility] |
| 20629-2 | levoFLOXacin [Susceptibility] |
| 18860-7 | Amikacin [Susceptibility] |
| 18935-7 | Kanamycin [Susceptibility] |
Russian
Сгенерированный нарратив: ValueSet dhis-observation-component-code-vs
Язык: uz
Этот набор значений включает коды, основанные на следующих правилах:
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs версия 📍0.1.0| Код | Отображение |
| tub004-0001 | INH ↑ MIK natijasi |
| tub004-0002 | INH ↓ MIK / ETH natijasi |
| tub004-0003 | FQL ↑ MIK natijasi |
| tub004-0004 | FQL ↓ MIK natijasi |
| tub004-0005 | AMK/KAN/CAP natijasi |
| tub004-0006 | AMK/KAN natijasi |
| tub004-0007 | Rifampitsin (1,0 mg/ml) |
| tub004-0008 | Izoniazid (0,1 mg/ml) |
| tub004-0009 | Etambutol (5,0 mg/ml) |
| tub004-0010 | Pirazinamid (100 mg/ml) |
| tub004-0011 | Levofloksatsin (2,0 mg/ml) |
| tub004-0012 | Moksifloksatsin (1,0 mg/ml) |
| tub004-0013 | Moksifloksatsin (0,25 mg/ml) |
| tub004-0014 | Gatifloksatsin (0,25 mg/ml) |
| tub004-0015 | Amikatsin (1,0 mg/ml) |
| tub004-0016 | Protionamid (2,5 mg/ml) |
| tub004-0017 | Linezolid (1,0 mg/ml) |
| tub004-0018 | Klofazimin (1,0 mg/ml) |
| tub004-0019 | Bedaquilin (1,0 mg/ml) |
| tub004-0020 | Delamanid (0,06 mg/ml) |
| tub004-0021 | Pretomanid (1,0 mg/ml) |
| tub004-0023 | Isoniazid ↑MIC |
| tub004-0024 | Isoniazid ↓MIC |
| tub004-0025 | Ethionamide-Prothionamide |
| tub004-0026 | Moxifloxacin ↑MIC |
| tub004-0027 | Moxifloxacin ↓MIC |
| tub004-0031 | CM/AS izolyatini identifikatsiya qilish |
| tub004-0032 | Gradatsiya |
| tub004-0033 | Kultura identifikatsiyasi |
| tub004-0034 | M. tuberculosis complex aniqlash natijasi |
| tub004-0035 | CM/AS izolyatini identifikatsiya qilish |
| tub004-0036 | ARVT (Antiretrovirusli terapiya) |
| tub004-0037 | KTR boshlandi |
http://loinc.org версия Not Stated (use latest from terminology server)| Код | Отображение |
| 18974-6 | |
| 20629-2 | |
| 18860-7 | |
| 18935-7 |
Uzbek
Generated Narrative: ValueSet dhis-observation-component-code-vs
Language: uz
This value set includes codes based on the following rules:
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs version 📍0.1.0| Code | Display |
| tub004-0001 | INH ↑ MIK natijasi |
| tub004-0002 | INH ↓ MIK / ETH natijasi |
| tub004-0003 | FQL ↑ MIK natijasi |
| tub004-0004 | FQL ↓ MIK natijasi |
| tub004-0005 | AMK/KAN/CAP natijasi |
| tub004-0006 | AMK/KAN natijasi |
| tub004-0007 | Rifampitsin (1,0 mg/ml) |
| tub004-0008 | Izoniazid (0,1 mg/ml) |
| tub004-0009 | Etambutol (5,0 mg/ml) |
| tub004-0010 | Pirazinamid (100 mg/ml) |
| tub004-0011 | Levofloksatsin (2,0 mg/ml) |
| tub004-0012 | Moksifloksatsin (1,0 mg/ml) |
| tub004-0013 | Moksifloksatsin (0,25 mg/ml) |
| tub004-0014 | Gatifloksatsin (0,25 mg/ml) |
| tub004-0015 | Amikatsin (1,0 mg/ml) |
| tub004-0016 | Protionamid (2,5 mg/ml) |
| tub004-0017 | Linezolid (1,0 mg/ml) |
| tub004-0018 | Klofazimin (1,0 mg/ml) |
| tub004-0019 | Bedaquilin (1,0 mg/ml) |
| tub004-0020 | Delamanid (0,06 mg/ml) |
| tub004-0021 | Pretomanid (1,0 mg/ml) |
| tub004-0023 | Isoniazid ↑MIC |
| tub004-0024 | Isoniazid ↓MIC |
| tub004-0025 | Ethionamide-Prothionamide |
| tub004-0026 | Moxifloxacin ↑MIC |
| tub004-0027 | Moxifloxacin ↓MIC |
| tub004-0031 | CM/AS izolyatini identifikatsiya qilish |
| tub004-0032 | Gradatsiya |
| tub004-0033 | Kultura identifikatsiyasi |
| tub004-0034 | M. tuberculosis complex aniqlash natijasi |
| tub004-0035 | CM/AS izolyatini identifikatsiya qilish |
| tub004-0036 | ARVT (Antiretrovirusli terapiya) |
| tub004-0037 | KTR boshlandi |
http://loinc.org version Not Stated (use latest from terminology server)| Code | Display |
| 18974-6 | |
| 20629-2 | |
| 18860-7 | |
| 18935-7 |
{
"resourceType": "ValueSet",
"id": "dhis-observation-component-code-vs",
"language": "uz",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://terminology.dhp.uz/fhir/integrations/ValueSet/dhis-observation-component-code-vs",
"version": "0.1.0",
"name": "DHISObservationComponentCodeVS",
"title": "DHIS Observation Component Code ValueSet",
"status": "draft",
"experimental": true,
"date": "2026-07-20T13:54:46+00:00",
"publisher": "Uzinfocom LLC",
"contact": [
{
"name": "Uzinfocom LLC",
"telecom": [
{
"system": "url",
"value": "https://uzinfocom.uz"
},
{
"system": "email",
"value": "info@uzinfocom.uz"
}
]
}
],
"description": "Value set of tuberculosis observation component codes. Plain drug-name DST agents use their LOINC [Susceptibility] code directly; concentration-bearing agents and non-drug component codes use local codes from the DHIS observation component code system.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "UZ",
"display": "Uzbekistan"
}
]
}
],
"compose": {
"include": [
{
"system": "https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs",
"version": "0.1.0",
"concept": [
{
"code": "tub004-0001"
},
{
"code": "tub004-0002"
},
{
"code": "tub004-0003"
},
{
"code": "tub004-0004"
},
{
"code": "tub004-0005"
},
{
"code": "tub004-0006"
},
{
"code": "tub004-0007"
},
{
"code": "tub004-0008"
},
{
"code": "tub004-0009"
},
{
"code": "tub004-0010"
},
{
"code": "tub004-0011"
},
{
"code": "tub004-0012"
},
{
"code": "tub004-0013"
},
{
"code": "tub004-0014"
},
{
"code": "tub004-0015"
},
{
"code": "tub004-0016"
},
{
"code": "tub004-0017"
},
{
"code": "tub004-0018"
},
{
"code": "tub004-0019"
},
{
"code": "tub004-0020"
},
{
"code": "tub004-0021"
},
{
"code": "tub004-0023"
},
{
"code": "tub004-0024"
},
{
"code": "tub004-0025"
},
{
"code": "tub004-0026"
},
{
"code": "tub004-0027"
},
{
"code": "tub004-0031"
},
{
"code": "tub004-0032"
},
{
"code": "tub004-0033"
},
{
"code": "tub004-0034"
},
{
"code": "tub004-0035"
},
{
"code": "tub004-0036"
},
{
"code": "tub004-0037"
}
]
},
{
"system": "http://loinc.org",
"concept": [
{
"code": "18974-6"
},
{
"code": "20629-2"
},
{
"code": "18860-7"
},
{
"code": "18935-7"
}
]
}
]
}
}